Cholangiocarcinoma Clinical Trials Cholangiocarcinoma RSS feedThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Cryoablation Combined With Sintilimab Plus Lenvatinib in 1L Treatment of Advanced ICC (CASTLE-ICC-Chemo-free)
Condition:   Advanced Intrahepatic Cholangiocarcinoma Interventions:   Procedure: Cryoablation;   Drug: Sintilimab;   Drug: Lenvatinib Sponsor:   Fudan University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 28, 2023 Category: Research Source Type: clinical trials

Lenvatinib, Tislelizumab Combined With Gemcitabine and Cisplatin (GPLET) in the Treatment of Advanced Cholangiocarcinoma
Condition:   Advanced Cholangiocarcinoma Interventions:   Drug: Lenvatinib, tislelizumab, gemcitabine and cisplatin;   Drug: Gemcitabine and cisplatin Sponsors:   Second Affiliated Hospital, School of Medicine, Zhejiang University;   The First Affiliated Hospital of Zhengzhou University;   The Affiliated Tumor Hospital of Xinjiang Medical University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 21, 2023 Category: Research Source Type: clinical trials